Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Sci Total Environ ; 921: 170934, 2024 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-38360330

RESUMEN

BACKGROUND: In the context of drug prohibition, potential adulteration and variable purity pose additional health risks for people who use drugs, with these risks often compounded by the outdoor music festival environment. Ahead of the imminent implementation of drug checking services in Queensland, Australia, this study aims to characterise this problem using triangulated survey and wastewater data to understand self-reported and detected drug use among attendees of a multi-day Queensland-based music festival in 2021 and 2022. METHODS: We administered an in-situ survey focusing on drug use at the festival to two convenience samples of 136 and 140 festival attendees in 2021 and 2022 respectively. We compared survey findings to wastewater collected concurrently from the festival's site-specific wastewater treatment plant, which was analysed using Liquid Chromatography Tandem Mass Spectrometry. RESULTS: Most survey respondents (82 % in 2021, 92 % in 2022) reported using or intending to use an illicit drug at the festival. Some respondents reported potentially risky drug use practices such as using drugs found on the ground (2 % in 2021, 4 % in 2022). Substances detected in wastewater but not surveys include MDEA, mephedrone, methylone, 3-MMC, alpha-D2PV, etizolam, eutylone, and N,N-dimethylpentylone. CONCLUSION: Many substances detected in wastewater but not self-reported in surveys likely represent substitutions or adulterants. These findings highlight the benefits of drug checking services to prevent harms from adulterants and provide education on safer drug use practices. These findings also provide useful information on socio-demographic characteristics and drug use patterns of potential users of Queensland's future drug checking service.


Asunto(s)
Música , Trastornos Relacionados con Sustancias , Humanos , Autoinforme , Aguas Residuales , Australia , Vacaciones y Feriados , Trastornos Relacionados con Sustancias/epidemiología
2.
Drug Alcohol Rev ; 41(4): 873-882, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-35139243

RESUMEN

INTRODUCTION: Understanding reasons for choosing not to inject drugs, among those who have never injected before, may be helpful for reducing transitions to injecting drug use. This study examines opportunities to inject and reasons for never injecting in young adults who used stimulants. METHODS: Data are from a population-based study of young adults who used ecstasy and methamphetamine (n = 313), recruited in Queensland, Australia in 2008/2009. At the follow-up, participants who had never injected (n = 293) completed a 13-item instrument on reasons for never injecting. We conducted a principal components analysis to identify types of reasons (scored 0-100) and multivariate regression to predict endorsement of these reasons. RESULTS: Approximately one-in-five of all participants ever had an opportunity to inject and there was no gender difference in the propensity to accept an opportunity. Four types of reasons, labelled risk perception, subjective effects, social environment and aversion, were identified. Male gender was associated with lower endorsement of risk perception (ß = -7.94; 95% confidence interval [CI] -13.37, -2.51) and social environment (ß = -7.35; 95% CI -13.15, -1.54). Having friends who injected was associated with lower endorsement of the social environment (ß = -8.88; 95% CI -14.83, -2.94), and higher endorsement of aversion (ß = 7.67; 95% CI 1.44, 13.89). DISCUSSION AND CONCLUSIONS: Our findings suggest that injecting drug use opportunities are common among young adults engaged in recreational drug use, with males and females equally likely to accept an opportunity. A strong aversion to injecting and a hedonic preference for non-injecting drug use may reduce the likelihood of accepting these opportunities.


Asunto(s)
Estimulantes del Sistema Nervioso Central , Metanfetamina , N-Metil-3,4-metilenodioxianfetamina , Abuso de Sustancias por Vía Intravenosa , Trastornos Relacionados con Sustancias , Australia/epidemiología , Femenino , Humanos , Masculino , Abuso de Sustancias por Vía Intravenosa/epidemiología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA